Enlightenment Research’s BioNTech BNTX Stock Holding History

Enlightenment Research’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-5,900	Closed	-$274K	–	145
2021 Q4	$274K	Buy	5,900 +2,700	+84%	+$739K	0.39%	81
2021 Q3	$874K	Buy	+3,200	New	+$1.02M	1.07%	29
2021 Q2	–	Sell	-4,400	Closed	-$480K	–	143
2021 Q1	$480K	Buy	4,400 +1,300	+42%	+$138K	0.58%	47
2020 Q4	$253K	Buy	+3,100	New	+$304K	0.36%	73

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Enlightenment Research's BNTX Position: Q1 2022 in Review

Enlightenment Research sold out of BioNTech (BNTX) in Q1 2022, closing a stake of 5,900 shares — an estimated $274K sold.

Enlightenment Research first reported a position in BNTX in Q4 2020 and held it in 4 quarters. The position peaked at $874K in Q3 2021. 287 funds tracked by Wall St. Rank hold BNTX as of Q1 2022.

Enlightenment Research reported no remaining BioNTech position as of Q1 2022 after selling out during the quarter.
Enlightenment Research sold 5,900 BioNTech shares in Q1 2022, an estimated $274K.
Enlightenment Research first reported a position in BioNTech in Q4 2020 and held it in 4 quarters.
Enlightenment Research's BioNTech position peaked at $874K in Q3 2021.
287 funds tracked by Wall St. Rank held BioNTech as of Q1 2022.

Based on Enlightenment Research's 13F filing for Q1 2022, filed 13 May 2022.